Heart Podcast Management of bicuspid aortic disease in the TAVI era
28 snips
Nov 5, 2024 Join Professor Marjan Jahangiri, a leading cardiac surgeon at St George's Hospital, as he unpacks the complexities of managing bicuspid aortic valve disease. He explores the role of Transcatheter Aortic Valve Implantation (TAVI) in treatment, discussing its risks and personalized care approaches. Delve into the genetic factors, clinical features, and post-operative monitoring necessary for optimal outcomes. Jahangiri also shares insights on future advancements and the importance of research in enhancing patient care.
AI Snips
Chapters
Transcript
Episode notes
Bicuspid Aortic Valve Disease Prevalence and Importance
- Bicuspid aortic valve disease (BAVD) is the most common congenital cardiac abnormality, affecting up to 2% of the population.
- It causes aortic stenosis or regurgitation 10-15 years earlier than tricuspid aortic valve disease.
BAVD Presentation and Symptoms
- BAVD patients typically present with aortic stenosis or regurgitation in their 50s, sometimes earlier.
- Some present with aortic dissection without prior knowledge of valve disease.
BAVD Inheritance and Family Screening
- Bicuspid aortic valve disease is rarely inherited, though some families have genetic predispositions.
- Scanning family members with transthoracic echocardiogram is recommended for early detection.